ACHE and early-onset autosomal dominant Alzheimer disease: Recently, Byler et al. concluded the potential activity of Boswellia resin in Alzheimer’s disease using a docking study, through its effect on acetylcholinesterase (AChE) (Byler and Setzer 2018).